Search research articles
Contact Us
Filters
Showing results (311-320 of 375) with videos related to
Page
of 38
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2018
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data
Matteo Lambertini, Halle C F Moore, Robert C F Leonard, et al.
JAMA Oncology
|
March 28, 2024
Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Pooled Analysis of CALGB 40601, NeoALTTO, and NSABP B-41 Trials
Aranzazu Fernandez-Martinez, Mattia Rediti, Gong Tang, et al.
The Lancet. Oncology
|
October 5, 2023
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement
Wanda Cui, Rodney P Rocconi, Ramya Thota, et al.
Cancer Treatment Reviews
|
June 19, 2023
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis
Carlotta Becherini, Luca Visani, Saverio Caini, et al.
Eclinicalmedicine
|
April 30, 2024
Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella and Mammella Intergruppo trials
Eva Blondeaux, Wanling Xie, Luca Carmisciano, et al.
Breast (Edinburgh, Scotland)
|
June 29, 2026
Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence
Rodrigo Sanchez-Bayona, Carey Anders, Rupert Bartsch, et al.
Breast Cancer Research and Treatment
|
December 28, 2017
Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06)
Noam Ponde, Ian Bradbury, Matteo Lambertini, et al.
The Lancet. Oncology
|
September 20, 2021
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial
Lucia Del Mastro, Mauro Mansutti, Giancarlo Bisagni, et al.
Clinical Breast Cancer
|
June 7, 2025
Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study
Soraia Lobo-Martins, Veronique Debien, Elisa Agostinetto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 6, 2026
Comparison of suboptimal versus adequate ovarian function suppression in premenopausal women with early breast cancer treated with adjuvant endocrine therapy: An exploratory analysis of two prospective studies
Simone Nardin, Marco Bruzzone, Luca Arecco, et al.
Page
of 38
Search research articles
Search
Showing results (311-320 of 375) with videos related to
Sort By:
Page
of 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2018
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data
Matteo Lambertini, Halle C F Moore, Robert C F Leonard, et al.
JAMA Oncology
|
March 28, 2024
Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Pooled Analysis of CALGB 40601, NeoALTTO, and NSABP B-41 Trials
Aranzazu Fernandez-Martinez, Mattia Rediti, Gong Tang, et al.
The Lancet. Oncology
|
October 5, 2023
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement
Wanda Cui, Rodney P Rocconi, Ramya Thota, et al.
Cancer Treatment Reviews
|
June 19, 2023
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis
Carlotta Becherini, Luca Visani, Saverio Caini, et al.
Eclinicalmedicine
|
April 30, 2024
Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella and Mammella Intergruppo trials
Eva Blondeaux, Wanling Xie, Luca Carmisciano, et al.
Breast (Edinburgh, Scotland)
|
June 29, 2026
Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence
Rodrigo Sanchez-Bayona, Carey Anders, Rupert Bartsch, et al.
Breast Cancer Research and Treatment
|
December 28, 2017
Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06)
Noam Ponde, Ian Bradbury, Matteo Lambertini, et al.
The Lancet. Oncology
|
September 20, 2021
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial
Lucia Del Mastro, Mauro Mansutti, Giancarlo Bisagni, et al.
Clinical Breast Cancer
|
June 7, 2025
Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study
Soraia Lobo-Martins, Veronique Debien, Elisa Agostinetto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 6, 2026
Comparison of suboptimal versus adequate ovarian function suppression in premenopausal women with early breast cancer treated with adjuvant endocrine therapy: An exploratory analysis of two prospective studies
Simone Nardin, Marco Bruzzone, Luca Arecco, et al.
Page
of 38